Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy

Cardiac hypertrophy, a major determinant of morbidity and mortality in hypertrophic cardiomyopathy (HCM), is considered a secondary phenotype and potentially preventable. To test this hypothesis, we screened 30 5- to 6-month-old β-myosin heavy chain Q403 transgenic rabbits by echocardiography and se...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Senthil, Vinitha, Chen, Suet N., Tsybouleva, Natalie, Halder, Tripti, Nagueh, Sherif F., Willerson, James T., Roberts, Robert, Marian, A.J.
Format: Artigo
Jezik:Inglês
Izdano: 2005
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1201449/
https://ncbi.nlm.nih.gov/pubmed/16020756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/01.RES.0000177090.07296.ac
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items